Safety Profile of Medicines Used for the Treatment of Drug-Resistant Tuberculosis: A Descriptive Study Based on the WHO Database (VigiBase<sup>®</sup>)

Background: The introduction of new drugs that increase the usage of repurposed medicines for managing drug-resistant tuberculosis (DR-TB) comes with challenges of understanding, properly managing, and predicting adverse drug reactions (ADRs). In addition to the health consequences of ADRs for the i...

ver descrição completa

Detalhes bibliográficos
Main Authors: Alemayehu Lelisa Duga, Francesco Salvo, Alexander Kay, Albert Figueras
Formato: Artigo
Idioma:English
Publicado em: MDPI AG 2023-04-01
Colecção:Antibiotics
Assuntos:
Acesso em linha:https://www.mdpi.com/2079-6382/12/5/811